clinical trial · NCT04871919
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
Alfasigma S.p.A.·—·active not recruiting·n = 1,304
Rheumatoid ArthritisFilgotinib
brief summary
An observational study to describe the effectiveness, safety, and patient-reported outcomes in patients with moderate to severe active rheumatoid arthritis (RA) receiving filgotinib in real-world setting.
started
May 11, 2021
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Sep 15, 2025
official title
A Prospective, Non-interventional Study of the Effectiveness, Safety, and Health Related Outcomes in Patients With Moderate to Severe Active Rheumatoid Arthritis Receiving Filgotinib
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol